Volume 38, Issue 2 supplement | European Journal of Clinical Pharmacology

Search all European Journal of Clinical Pharmacology articles

Volume 38, Issue 2 supplement

March 1990

Filter by

Volume:

Sort by

Date published:

New to old Old to new

21 articles in this issue

Pharmacology of antihypertensive agents with multiple actions
P. A. van Zwieten
Pharmacology and Hemodynamics Pages: S77 - S81
The pharmacology of carvedilol
R. R. Ruffolo Jr
M. Gellai
A. J. Nichols
Pharmacology and Hemodynamics Pages: S82 - S88
The role of multiple action agents in hypertension
P. Lund-Johansen
P. Omvik
Pharmacology and Hemodynamics Pages: S89 - S95
Effects of carvedilol on renal function
A. G. Dupont
Pharmacology and Hemodynamics Pages: S96 - S100
Hemodynamic profile of carvedilol
V. Hombach
M. Kochs
A. Schmidt
Pharmacology and Hemodynamics Pages: S101 - S103
Pharmacological characteristics of the stereoisomers of carvedilol
W. Bartsch
G. Sponer
H. O. Borbe
Poster Presentations Pages: S104 - S107
Stereoselective disposition of carvedilol in man after intravenous and oral administration of the racemic compound
G. Neugebauer
W. Akpan
K. Reiff
Poster Presentations Pages: S108 - S111
Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation
R. R. Ruffolo Jr
C. F. Sauermelch
R. N. Willette
Poster Presentations Pages: S112 - S114
Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension
Y. Nagakawa
Y. Akedo
H. Orimo
Poster Presentations Pages: S115 - S119
Effects of carvedilol on cerebral blood flow and its autoregulation in previous stroke patients with hypertension
Y. Kuriyama
M. Nakamura
T. Sawada
Poster Presentations Pages: S120 - S121
Influence of carvedilol and propranolol on coronary blood flow
H. Sievert
G. Frey
G. Kober
Poster Presentations Pages: S122 - S124
Are different hemodynamic patterns of antihypertensive drugs clinically important?
S. Julius
Clinical Efficacy and Safety Pages: S125 - S128
The use of carvedilol in elderly hypertensive patients
T. O. Morgan
A. Anderson
W. Adam
Clinical Efficacy and Safety Pages: S129 - S133
Do different hemodynamic effects of antihypertensive drugs translate into different safety profiles?
M. Moser
Clinical Efficacy and Safety Pages: S134 - S138
Effects of carvedilol on serum lipids in hypertensive and normotensive subjects
H. Seguchi
H. Nakamura
S. Takahashi
Poster Presentations Pages: S139 - S142
Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide
L. Widmann
R. van der Does
M. Machwirth
Poster Presentations Pages: S143 - S146
Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide
R. van der Does
L. Widmann
U. Stienen
Poster Presentations Pages: S147 - S152
The safety of adding carvedilol to hypertensive patients inadequately treated with diuretics
A. G. Dupont
D. F. Schoors
R. P. Venuti
Poster Presentations Pages: S153 - S157
Efficacy and safety of carvedilol in renal hypertension
T. Takeda
M. Kohno
M. Yoshimura
Poster Presentations Pages: S158 - S163
Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension
J. P. Ollivier
P. Durier
J. L. Gayet
Poster Presentations Pages: S164 - S166
Blood-pressure-lowering effect of carvedilol vs nitrendipine in geriatric hypertensives
B. Krönig
L. Widmann
B. Müller-Beckmann
Poster Presentations Pages: S167 - S170